Biotechnology Stocks I Performance Guide: Protagonist Therapeutics, Inc. (PTGX)
PTGX has no dividends.
Table and Chart of PTGX Performance
See what a $1,000 investment in PTGX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| PTGX Returns | |
|---|---|
| Start Date | Sep-30-2016 |
| Start Price | $21.13 |
| End Date | Jul-26-2024 |
| End Price | $40.28 |
| # Prices | 95 |
| Min Date | Nov-30-2018 |
| Min Price | $6.47 |
| Max Date | Jul-30-2021 |
| Max Price | $49.43 |
| Total Return | 90.63% |
| Annualized Return | 8.49% |
| Current Value of $1,000 Purchase | $1,906 |
| Number Returns | 4,465 |
| Average Return | 61.07% |
| Number Profitable Returns | 2,807 |
| Percent Profitable Returns | 62.87% |
| Number Unprofitable Returns | 1,658 |
| Percent Unprofitable Returns | 37.13% |
| Profitable to Unprofitable Returns Ratio | 1.69 |
| PTGX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,404,150,000 |
| Beta | 2.122 | Price to Sales | 26.26 |
| Earnings per Share | $2.5400 |
| PE Ratio | 16.14 |
| PE to Growth Ratio | 0 |
| Price to Book | 4.68 |
| PRICE DATA | |
| 52 Week High | $42.67 |
| 52 Week Low | $13.72 |
| Analyst Target Price | $46.8 |
| 50-Day Moving Average | $33.36 |
| 200-Day Moving Average | $25.9 |
| FINANCIAL DATA | |
| Revenue per Share | $5.31 |
| Revenue | $314,953,000 |
| Profit Margin | 51.5% |
| Return on Equity | 41.7% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
PTGX Compare Returns with S&P 500
PTGX Trendline Chart
PTGX Moving Average Chart
PTGX Stock Return Map - See Patterns of Gains and Losses
PTGX Stock Returns/Purchase Dates